Back to Search
CHRISTOPHER BALLANTYNE, M.D.
M.D.
Urology Physician
NPI: 1700317906IndividualAccepts Medicare
Education
UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Class of 2020
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
NCT00988364COMPLETEDPHASE4STUDY_DIRECTOR
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
NCT00687076COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT).
PMID 24267254·Atherosclerosis·2013
4-observational
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
PMID 21227624·J Vasc Surg·2011
4-observational
Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management.
PMID 17345122·World J Surg·2007
6-review
Pro-apoptotic low-density lipoprotein subfractions in type II diabetes.
PMID 17030034·Atherosclerosis·2007
7-preclinical
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
PMID 15383192·Curr Med Res Opin·2004
3-trial
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
PMID 14757686·Circulation·2004
8-other
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
PMID 12719279·Circulation·2003
3-trial
Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.
PMID 12695302·Circulation·2003
7-preclinical
Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.
PMID 12689919·Arterioscler Thromb Vasc Biol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1215 LEE ST
CHARLOTTESVILLE, VA 22908 - Phone
- (434) 924-2150
Quick Facts
- NPI
- 1700317906
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 6
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile